By Marissa Moore, CFA and Taku Murahwi While the interplay of factors that make a specific vertical more ready than others for AI-powered innovation is complex, we identified a few factors… Read More »What makes an industry well-suited for vertical AI?
Written by Marissa Moore and Taku Murahwi. Vertical software is naturally an area of intense business transformation, and dramatic, fundamental shifts. To keep on top of what industries and categories… Read More »Where we’re looking to invest in vertical B2B software & AI
Written by Dave Wechsler. The Insurtech category is starting to bounce back. Coming off investment lows of ’22 and ’23, there’s renewed interest from the VC community in Insurtechs… Read More »Optimizing your Insurtech for venture investment
By Marissa Moore, CFA and Taku Murahwi At this point, we all know AI is drastically changing many job functions, across many industries. But not all verticals are created equal — and… Read More »Mapping the impending impact of Vertical AI
Why Regular Cleaning is Essential Regular cleaning is essential for maintaining the performance and longevity of your computer system. Over time, dust, dirt, and debris can accumulate on the various… Read More »Keep Your Computer Sparkling Clean
The admitted white nationalist terrorist committed the vilest of crimes against London, Ontario’s Afzaal family because they were Muslim The admitted white nationalist terrorist committed the vilest of crimes against… Read More »The Terrorist: How a devout Christian kid became a radicalized mass murderer
A developer platform to solve the notification bell Knock cofounders Chris Bell & Sam Seely We’re excited to announce that Craft has led the $12 million Series A in Knock, the… Read More »Why We Invested in Knock
By Mike Marg and Justin Reidy, Craft Ventures It’s been a little over a year since the AI gold rush was ignited by the launch of ChatGPT. We’ve seen countless, excellent… Read More »The AI Simple Stack
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option Closes acquisition of exclusive, worldwide license to Tolimidone, Phase… Read More »Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
Here on OMERS Ventures’ vertical SaaS team, we make a practice of doing deep dives into specific verticals we think are particularly well suited for breakout vertical SaaS companies.… Read More »Dental vertical software: drilling into trends and opportunities